755 related articles for article (PubMed ID: 28664292)
1. Uric acid is independent cardiovascular risk factor, as manifested by increased carotid intima-media thickness in rheumatoid arthritis patients.
Hannawi S; AlSalmi I; Moller I; Naredo E
Clin Rheumatol; 2017 Aug; 36(8):1897-1902. PubMed ID: 28664292
[TBL] [Abstract][Full Text] [Related]
2. Subclinical atherosclerosis among rheumatoid arthritis patients without overt cardiovascular risk factors.
Sahari NS; Shaharir SS; Ismail MR; Rajalingham S; Mohamed Said MS
Mod Rheumatol; 2014 Nov; 24(6):920-5. PubMed ID: 24645724
[TBL] [Abstract][Full Text] [Related]
3. [Subclinical markers of atherosclerosis and cardiovascular risk factors in early arthritis].
Gobbi CA; Asbert P; Alba PB; Resk J; Dotto G; Demarchi M; Cuvertino E; Pepe GA; Salica DA; Albiero EH; Martínez F
Rev Fac Cien Med Univ Nac Cordoba; 2019 Aug; 76(3):174-179. PubMed ID: 31465186
[TBL] [Abstract][Full Text] [Related]
4. The relationship between carotid intima-media thickness and the activity of rheumatoid arthritis.
Targońska-Stepniak B; Drelich-Zbroja A; Majdan M
J Clin Rheumatol; 2011 Aug; 17(5):249-55. PubMed ID: 21778898
[TBL] [Abstract][Full Text] [Related]
5. Association of Cardiovascular Risk Factors with Carotid Intima Media Thickness in Patients with Rheumatoid Arthritis with Low Disease Activity Compared to Controls: A Cross-Sectional Study.
van Breukelen-van der Stoep DF; van Zeben D; Klop B; van de Geijn GJ; Janssen HJ; Hazes MJ; Birnie E; van der Meulen N; De Vries MA; Castro Cabezas M
PLoS One; 2015; 10(10):e0140844. PubMed ID: 26485681
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of anticyclic citrullinated peptide antibodies, interleukin-6, tumor necrosis factor-α, and C-reactive protein are associated with increased carotid intima-media thickness: a cross-sectional analysis of a cohort of rheumatoid arthritis patients without cardiovascular risk factors.
Vázquez-Del Mercado M; Nuñez-Atahualpa L; Figueroa-Sánchez M; Gómez-Bañuelos E; Rocha-Muñoz AD; Martín-Márquez BT; Corona-Sanchez EG; Martínez-García EA; Macias-Reyes H; Gonzalez-Lopez L; Gamez-Nava JI; Navarro-Hernandez RE; Nuñez-Atahualpa MA; Andrade-Garduño J
Biomed Res Int; 2015; 2015():342649. PubMed ID: 25821796
[TBL] [Abstract][Full Text] [Related]
7. Association Between Uric Acid, Carotid Intima-Media Thickness, and Cardiovascular Events: Prospective Results From the IMPROVE Study.
Mannarino MR; Pirro M; Gigante B; Savonen K; Kurl S; Giral P; Smit A; Veglia F; Tremoli E; Baldassarre D;
J Am Heart Assoc; 2021 Jun; 10(11):e020419. PubMed ID: 33998285
[TBL] [Abstract][Full Text] [Related]
8. Associations between serum uric acid and markers of subclinical atherosclerosis in young adults. The cardiovascular risk in Young Finns study.
Oikonen M; Wendelin-Saarenhovi M; Lyytikäinen LP; Siitonen N; Loo BM; Jula A; Seppälä I; Saarikoski L; Lehtimäki T; Hutri-Kähönen N; Juonala M; Kähönen M; Huupponen R; Viikari JS; Raitakari OT
Atherosclerosis; 2012 Aug; 223(2):497-503. PubMed ID: 22749515
[TBL] [Abstract][Full Text] [Related]
9. Variables associated with subclinical atherosclerosis among rheumatoid arthritis patients of Gulf Cooperative Council countries.
Hannawi S; Hannawi H; Alokaily F; Al Salmi I
Saudi Med J; 2020 Feb; 41(2):128-137. PubMed ID: 32020145
[TBL] [Abstract][Full Text] [Related]
10. Subclinical impairment of myocardial and endothelial functionality in very early psoriatic and rheumatoid arthritis patients: Association with vitamin D and inflammation.
Lo Gullo A; Rodríguez-Carrio J; Aragona CO; Dattilo G; Zito C; Suárez A; Loddo S; Atteritano M; Saitta A; Mandraffino G
Atherosclerosis; 2018 Apr; 271():214-222. PubMed ID: 29524864
[TBL] [Abstract][Full Text] [Related]
11. Traditional cardiovascular risk factors or inflammation: Which factors accelerate atherosclerosis in arthritis patients?
Dalbeni A; Giollo A; Tagetti A; Atanasio S; Orsolini G; Cioffi G; Ognibeni F; Rossini M; Minuz P; Fava C; Viapiana O
Int J Cardiol; 2017 Jun; 236():488-492. PubMed ID: 28109577
[TBL] [Abstract][Full Text] [Related]
12. Predictive Value of Arterial Stiffness and Subclinical Carotid Atherosclerosis for Cardiovascular Disease in Patients with Rheumatoid Arthritis.
Ikdahl E; Rollefstad S; Wibetoe G; Olsen IC; Berg IJ; Hisdal J; Uhlig T; Haugeberg G; Kvien TK; Provan SA; Semb AG
J Rheumatol; 2016 Sep; 43(9):1622-30. PubMed ID: 27307523
[TBL] [Abstract][Full Text] [Related]
13. Circulating concentrations of the novel adipokine chemerin are associated with cardiovascular disease risk in rheumatoid arthritis.
Dessein PH; Tsang L; Woodiwiss AJ; Norton GR; Solomon A
J Rheumatol; 2014 Sep; 41(9):1746-54. PubMed ID: 25028378
[TBL] [Abstract][Full Text] [Related]
14. [Cardiovascular diseases in rheumatoid arthritis].
Popkova TV; Khelkovskaia AN; Mach ES; Aleksandrova EN; Novikov AA; Novikova DS; Nasonov EL
Ter Arkh; 2007; 79(5):9-14. PubMed ID: 17672067
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis.
Dessein PH; Joffe BI; Singh S
Arthritis Res Ther; 2005; 7(3):R634-43. PubMed ID: 15899050
[TBL] [Abstract][Full Text] [Related]
16. Increased progression of carotid intima media thickness in thyroid peroxidase antibodies-positive rheumatoid arthritis patients.
Raterman HG; Voskuyl AE; Simsek S; Schreurs MW; van Hoogstraten IM; Peters MJ; van Halm VP; Dijkmans BA; Lips P; Lems WF; Nurmohamed MT
Eur J Endocrinol; 2013 Dec; 169(6):751-7. PubMed ID: 24005313
[TBL] [Abstract][Full Text] [Related]
17. Comparable effects of traditional cardiovascular risk factors on subclinical atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis.
Quevedo-Abeledo JC; Rúa-Figueroa Í; Sánchez-Pérez H; Naranjo A; de Armas-Rillo L; Tejera-Segura B; Lopez-Mejías R; González-Gay MÁ; Ferraz-Amaro I
Clin Exp Rheumatol; 2020; 38(5):917-924. PubMed ID: 31969232
[TBL] [Abstract][Full Text] [Related]
18. The role of microalbuminuria as a predictor of subclinical cardiovascular events in rheumatoid arthritis patients and its relation to disease activity.
Nada DW; El Morsy S; Abu-Zaid MH; Aboelhawa MA; Zakaria MA; El Sheikh EA; Gaber RA
Clin Rheumatol; 2018 Mar; 37(3):623-630. PubMed ID: 29063462
[TBL] [Abstract][Full Text] [Related]
19. The comparison of cardiovascular disease risk prediction scores and evaluation of subclinical atherosclerosis in rheumatoid arthritis: a cross-sectional study.
Muhammed H; Misra DP; Jain N; Ganguly S; Pattanaik SS; Rai MK; Anuja AK; Mohindra N; Kumar S; Agarwal V
Clin Rheumatol; 2022 Dec; 41(12):3675-3686. PubMed ID: 36006556
[TBL] [Abstract][Full Text] [Related]
20. Evidence for increased chylomicron remnants in rheumatoid arthritis.
Burggraaf B; van Breukelen-van der Stoep DF; van Zeben J; van der Meulen N; van de Geijn GM; Liem A; Valdivielso P; Rioja Villodres J; Ramírez-Bollero J; van der Zwan E; Castro Cabezas M
Eur J Clin Invest; 2018 Feb; 48(2):. PubMed ID: 29231984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
